Albireo Pharma Net Tangible Assets

Albireo Pharma (ALBO) currently reports a net tangible assets of $83M as of September 2022. That compares with $160M in the prior-year period — down 49.6% year over year. Use the charts on this page to explore Albireo Pharma's net tangible assets history and peer comparisons.

Albireo Pharma's net tangible assets decreased from $160M to $83M — a 49.6% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Albireo Pharma reported $83M in net tangible assets as of September 2022. That compares with $160M in the prior-year period — down 49.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $83M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Albireo Pharma, and consider following ALBO for alerts when major investors trade the stock.

Albireo Pharma is classified in the Healthcare sector. On net tangible assets, it currently shows $83M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALBO with unrelated industries.